Immunotherapy Tolerable for Cancer Patients With Rheumatologic Disease – Oncology Nurse Advisor
Oncology Nurse Advisor |
Immunotherapy Tolerable for Cancer Patients With Rheumatologic Disease
Oncology Nurse Advisor For this retrospective study, researchers identified 16 patients with rheumatologic disease (eg, rheumatoid arthritis, polymyalgia rheumatica) who later developed cancer and were treated with immune checkpoint inhibitors such as ipilimumab, nivolumab … |
